Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome

    loading  Checking for direct PDF access through Ovid

Abstract

(Abstracted from N Engl J Med 2017;376:2341–2348)

Neonates born to women who are addicted to opioids are at high risk of developing neonatal abstinence syndrome (NAS). Traditional treatment commonly includes the use of morphine, but this treatment often leads to a prolonged hospitalization.

Related Topics

    loading  Loading Related Articles